TNDM - Tandem Diabetes Care, Inc.
64.04 0.00 (0.00%)
After hours: 7:49PM EDT
| Previous Close | 65.40 |
| Open | 65.50 |
| Bid | 64.04 x 1300 |
| Ask | 64.15 x 800 |
| Day's Range | 63.55 - 66.00 |
| 52 Week Range | 20.08 - 74.81 |
| Volume | 870,760 |
| Avg. Volume | 1,709,926 |
| Market Cap | 3.719B |
| Beta (3Y Monthly) | -0.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.94 |
| Earnings Date | Jul 29, 2019 - Aug 2, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 80.00 |
- Simply Wall St.•5 days ago
When Can We Expect A Profit From Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM): Tandem Diabetes Care, Inc., a medical device company, designs, develops...
- Business Wire•5 days ago
Tandem Diabetes Care Announces Upcoming Conference Presentation
Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present at the BMO 2019 Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 in New York at 1:20pm Eastern Time .
- PR Newswire•6 days ago
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Tandem Diabetes Care, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
NEW YORK , June 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty ...
- Business Wire•12 days ago
CORRECTING and REPLACING Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology
Fourth paragraph, fourth sentence of release dated June 9, 2019, should read: Time spent below 70 mg/dL was 1.4 percent with Control-IQ technology compared to 1.9 percent in the control group (p
- Market Realist•13 days ago
How Tandem Diabetes Care Is Advancing Its Product Pipeline
Tandem Diabetes Care (TNDM) plans to file an application seeking FDA approval for use of its Control-IQ technology in t: slim X2 insulin pumps for patients aged 14 and above.
- Insider Monkey•14 days ago
Hedge Funds Have Never Been This Bullish On Tandem Diabetes Care Inc (TNDM)
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
- Market Realist•14 days ago
What Are Tandem Diabetes Care’s Key Growth Drivers in 2019?
Tandem Diabetes Care or Insulet: Which Is a Better Pick in June?(Continued from Prior Part)First automated insulin delivery pumpTandem Diabetes Care’s (TNDM) automated insulin delivery system, t: slim X2 Insulin Pump with Basal-IQ technology,
- Market Realist•14 days ago
Tandem or Insulet: Who Is Reporting Faster Pump Uptake?
Tandem Diabetes Care or Insulet: Which Is a Better Pick in June?(Continued from Prior Part)Tandem Diabetes Care’s pump demandIn the first quarter, Tandem Diabetes Care (TNDM) shipped 14,700 insulin pumps, a YoY rise of 232%. The demand rose
- Market Realist•15 days ago
Tandem Diabetes and Insulet: Comparing Revenue Growth
Tandem Diabetes Care or Insulet: Which Is a Better Pick in June?(Continued from Prior Part)Tandem Diabetes Care’s revenue trajectoryIn its first-quarter earnings conference call, Tandem Diabetes Care (TNDM) increased its fiscal 2019 revenue
- Motley Fool•15 days ago
Why DexCom Stock Jumped Today
Good news for the company's G6 CGM system translated to a nice gain.
- Market Realist•15 days ago
How Analysts Rate Tandem Diabetes Care and Insulet
Tandem Diabetes Care or Insulet: Which Is a Better Pick in June?Evolving insulin delivery landscapeUntil the start of 2017, the insulin pump technology space was mainly dominated by big companies such as Medtronic (MDT) and Johnson & Johnson
- Zacks•15 days ago
Tandem Releases Positive Results Of t:slim X2 Pump Studies
The results of the studies are a major breakthrough for Tandem (TNDM) in the field of diabetes treatment.
- Business Wire•16 days ago
Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology
Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, today announced positive results from two studies of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology. The t:slim X2 insulin pump with Control-IQ technology utilizes Dexcom G6 continuous glucose monitoring (CGM) sensor values to predict glucose levels and adjust insulin delivery to prevent highs and lows, while still allowing the user to manually bolus for meals.
- Business Wire•18 days ago
Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions
Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced that management will hold a conference call on Sunday, June 9, 2019 at 8:00pm Eastern Time following data presentations at the 79th Scientific Sessions of the American Diabetes Association on its t:slim X2 with Control-IQ technology system.
- Zacks•26 days ago
Why Is Tandem Diabetes (TNDM) Up 9.7% Since Last Earnings Report?
Tandem Diabetes (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•last month
Here's Why You Should Hold on to Tandem (TNDM) Stock for Now
Investor confidence in Tandem Diabetes (TNDM) is still high on several positive factors.
Investor's Business Daily•last monthIBD Stock Of The Day Flirts With A Breakout As It Takes On Medtronic
Tandem Diabetes is the IBD Stock Of The Day after the medical device company knocked its first-quarter results out of the park this month. Now, Tandem stock is approaching a breakout.
- Simply Wall St.•last month
Imagine Holding Tandem Diabetes Care (NASDAQ:TNDM) Shares While The Price Zoomed 423% Higher
While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...
- Business Wire•last month
Tandem Diabetes Care Announces Upcoming Conference Presentations
Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced that management will present a Company update at the followin
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of TNDM earnings conference call or presentation 30-Apr-19 8:30pm GMT
Q1 2019 Tandem Diabetes Care Inc Earnings Call
- Motley Fool•2 months ago
Who Had the Better Quarter, Tandem Diabetes or Teladoc?
These two disruptive companies reported crazy-good top-line growth, but only one can be the winner.
- Motley Fool•2 months ago
Why Diabetes-Disruptor Insulet Is Skyrocketing 10% Today
The insulin pump maker reported better-than-expected first-quarter financials and issued a rosier outlook for 2019.
- MarketWatch•2 months ago
The stock market’s reaction to this one word from the Fed’s Powell shows investors should be careful
Sometimes the U.S. stock market sends a clear, unambiguous message. The message the stock market sent during Federal Reserve Chairman Jerome Powell’s press conference Wednesday says that the market is vulnerable. • The chart shows that the stock market rose immediately after the Fed decision was announced.
- Zacks•2 months ago
Tandem's (TNDM) Q1 Loss Wider Than Expected, Sales Top Mark
Tandem's (TNDM) introduction of t:slim X2 with Basal-IQ technology, ramped-up supply capacity along with its global launch, substantially drive its top line in Q1.
Motley Fool•2 months agoTandem Diabetes Care Inc (TNDM) Q1 2019 Earnings Call Transcript
TNDM earnings call for the period ending March 31, 2019.
